Reuters - Daily Investor Update

Click to View in Browser

Tuesday, December 5, 2017

Canada scraps plan to buy Boeing fighters amid trade dispute: sources

OTTAWA (Reuters) - Canada is scrapping a plan to buy 18 Boeing Co Super Hornet fighter jets amid a deepening dispute with the U.S. aerospace company, three sources familiar with the matter said on Tuesday.

S&P falls for third session as tech rebound wilts

(Reuters) - Stocks on Wall Street fell on Tuesday as a technology rebound lost steam and Walt Disney Co dipped, while investors assessed how a Republican tax overhaul would impact corporate earnings.

General Electric to cut 4,500 jobs in Europe: report

PARIS (Reuters) - U.S. firm General Electric will cut 4,500 jobs across Europe after reviewing assets it purchased from France's Alstom in 2015, French newspaper Les Echos said on Tuesday.

Disney's bid for Fox assets gains momentum: sources

(Reuters) - Walt Disney Co is in the lead to acquire much of Twenty-First Century Fox Inc's media empire, though rival suitor Comcast Corp remains in contention, people familiar with the matter said on Tuesday.

Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

(Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.

Amid rising discounts, Nissan seeks 'fair share' of pie in U.S.: executive

(This version of the Dec. 4 story corrects and recasts paragraph 10 to show status of 2018 year model vehicles)

Exxon takes climate-change probe fight to Massachusetts top court

BOSTON (Reuters) - Exxon Mobil Corp urged Massachusetts' top court on Tuesday to block the state's attorney general from obtaining records to investigate whether the company for decades concealed its knowledge of the role fossil fuels have on climate change.

Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

LONDON (Reuters) - Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare as it seeks to offset weakness in packaged foods.

Copper falls to two-month low; tech stocks rebound

NEW YORK (Reuters) - Copper prices fell steeply to their lowest point in two months on Tuesday, while technology stocks rebounded following a rotation away from the high-flying group as investors assessed a U.S. tax-cut proposal.

CVS likely wants FTC antitrust review, not Justice Department, of Aetna deal

WASHINGTON (Reuters) - It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.